Immunic Inc (IMUX) Event Aug. 04, 2022, 00:00 UTC (28% Negative) Immunic, Inc. (IMUX) Reports Net Loss for 2022-06-30 Full text
Register to leave comments News bot Oct. 29, 2025, 10:53 a.m. 🏢 Immunic Inc (IMUX) - Form 10-Q Quarterly Report Quarterly financial filing submitted to the SEC 📋 Filing Information 📄 Form Type: 10-Q 📅 Filing Date: 2022-08-04 📊 Period of Report: 2022-06-30 ⏰ Accepted: N/A 📊 Key Financial Metrics (Period-over-Period Comparison) Metric Current Period Previous Period Change ($) Change (%) Trend Net Income/Loss $-52.47M $-42.71M $-9.76M -22.85% 📈 Total Assets $139.10M $138.66M $443.00K +0.32% ↗️ Total Liabilities $11.98M $10.81M $1.18M +10.88% 📉 Stockholders' Equity $120.74M $-156.40M $277.14M +177.20% 📈 Operating Income/Loss $-51.56M $-42.05M $-9.51M -22.62% 📈 R&D Expense $27.26M $33.98M $-6.73M -19.79% 📈 Earningspersharebasic $-2.44 $-1.49 $-0.95 -63.76% 📉 Earningspersharediluted $-2.44 $-1.49 $-0.95 -63.76% 📉 📈 Financial Trend Analysis 🔻 Reported net loss for the period • ⚖️ Liability growth outpaced asset growth 📎 View Full 10-Q Filing on SEC.gov Access the complete official filing document
🏢 Immunic Inc (IMUX) - Form 10-Q Quarterly Report
📋 Filing Information
Key Financial Metrics (Period-over-Period Comparison)
Financial Trend Analysis
🔻 Reported net loss for the period • ⚖️ Liability growth outpaced asset growth
📎 View Full 10-Q Filing on SEC.gov
Access the complete official filing document